Phase II trial of seridopine as adjunctive therapy in patients with schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2011
At a glance
- Drugs Seridopidine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors NeuroSearch
- 28 Apr 2011 Planned initiation date changed to 1 Dec 2011.
- 02 May 2010 According to a NeuroSearch media release, planning and preparation for the trial is almost finalised.
- 02 May 2010 New trial record.